Ahmed W - Search Results

1

Modelling the Costs of Sublingual Immunotherapy versus Subcutaneous Immunotherapy Based on Clinical Appointments and Impacts of Patient Travel in Sweden.

Cardell LO, Sterner T, Ahmed W, Slættanes AK, Svärd M, Pollock RF. Cardell LO, et al. Among authors: ahmed w. Clinicoecon Outcomes Res. 2024 Jun 10;16:493-506. doi: 10.2147/CEOR.S462698. eCollection 2024. Clinicoecon Outcomes Res. 2024. PMID: 38882235 Free PMC article.

2

Evaluating the cost-utility of intravesical Bacillus Calmette-Guérin versus radical cystectomy in patients with high-risk non-muscle-invasive bladder cancer in the UK.

Grabe-Heyne K, Henne C, Odeyemi I, Pöhlmann J, Ahmed W, Pollock RF. Grabe-Heyne K, et al. Among authors: ahmed w. J Med Econ. 2023 Jan-Dec;26(1):411-421. doi: 10.1080/13696998.2023.2189860. J Med Econ. 2023. PMID: 36897006 Free article.

3

Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose and intermittently scanned continuous glucose monitoring in people with type 1 diabetes receiving multiple daily insulin injections in Denmark.

Alshannaq H, Cogswell G, Pollock RF, Ahmed W, Norman GJ, Lynch PM, Roze S. Alshannaq H, et al. Among authors: ahmed w. Diabetes Obes Metab. 2023 Sep;25(9):2704-2713. doi: 10.1111/dom.15158. Epub 2023 Jun 19. Diabetes Obes Metab. 2023. PMID: 37334522

4

Modelling the impact of sublingual immunotherapy versus subcutaneous immunotherapy on patient travel time and CO₂ emissions in Sweden.

Cardell LO, Sterner T, Ahmed W, Slættanes AK, Svärd M, Pollock RF. Cardell LO, et al. Among authors: ahmed w. Sci Rep. 2024 Jan 18;14(1):1575. doi: 10.1038/s41598-024-51925-8. Sci Rep. 2024. PMID: 38238479 Free PMC article.

5

Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France.

Alshannaq H, Pollock RF, Joubert M, Ahmed W, Norman GJ, Lynch PM, Roze S. Alshannaq H, et al. Among authors: ahmed w. J Comp Eff Res. 2024 Mar;13(3):e230174. doi: 10.57264/cer-2023-0174. Epub 2024 Jan 31. J Comp Eff Res. 2024. PMID: 38294332 Free PMC article.

6

Cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anemia in England.

Iqbal TH, Kennedy N, Dhar A, Ahmed W, Pollock RF. Iqbal TH, et al. Among authors: ahmed w. J Med Econ. 2024 Jan-Dec;27(1):392-403. doi: 10.1080/13696998.2024.2313932. Epub 2024 Mar 11. J Med Econ. 2024. PMID: 38391240 Free article. Clinical Trial.

7

Real-time continuous glucose monitoring vs. self-monitoring of blood glucose: cost-utility in South Korean type 2 diabetes patients on intensive insulin.

Kim JY, Ilham S, Alshannaq H, Pollock RF, Ahmed W, Norman GJ, Jin SM, Kim JH. Kim JY, et al. Among authors: ahmed w. J Med Econ. 2024 Jan-Dec;27(1):1245-1252. doi: 10.1080/13696998.2024.2405293. Epub 2024 Sep 24. J Med Econ. 2024. PMID: 39275990 Free article.

8

A Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in Patients with Iron Deficiency Anemia in China.

Zhang F, Shen A, Ahmed W, Pollock RF. Zhang F, et al. Among authors: ahmed w. Adv Ther. 2024 Nov;41(11):4191-4204. doi: 10.1007/s12325-024-02987-7. Epub 2024 Sep 18. Adv Ther. 2024. PMID: 39292421 Free PMC article.

9

Cost-Utility of Real-Time Continuous Glucose Monitoring versus Self-Monitoring of Blood Glucose in People with Insulin-Treated Type 2 Diabetes in Spain.

Merino-Torres JF, Ilham S, Alshannaq H, Pollock RF, Ahmed W, Norman GJ. Merino-Torres JF, et al. Among authors: ahmed w. Clinicoecon Outcomes Res. 2024 Nov 5;16:785-797. doi: 10.2147/CEOR.S483459. eCollection 2024. Clinicoecon Outcomes Res. 2024. PMID: 39525696 Free PMC article.

10

The Health Economics of Automated Insulin Delivery Systems and the Potential Use of Time in Range in Diabetes Modeling: A Narrative Review.

Mathieu C, Ahmed W, Gillard P, Cohen O, Vigersky R, de Portu S, Ozdemir Saltik AZ. Mathieu C, et al. Among authors: ahmed w. Diabetes Technol Ther. 2024 Mar;26(S3):66-75. doi: 10.1089/dia.2023.0438. Diabetes Technol Ther. 2024. PMID: 38377319 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,473 results

Search Page

Filters